From: Proceedings of Réanimation 2020, the French Intensive Care Society International Congress
Substances | n | IC 0.25 | Serious adverse events, n | Serious adverse events, % | Fatal adverse events, n | Fatal adverse events, % |
---|---|---|---|---|---|---|
Valproic acid | 1260 | 6.86 | 768 | 61 | 54 | 4 |
Fluorouracil | 221 | 4.27 | 213 | 96 | 20 | 9 |
Topiramate | 96 | 4.33 | 65 | 68 | 0 | 0 |
Oxaliplatin | 74 | 2.53 | 68 | 92 | 12 | 16 |
Asparaginase | 71 | 5.09 | 50 | 70 | 6 | 8 |
Levofolinic acid | 51 | 5.44 | 51 | 100 | 6 | 12 |
Paracetamol | 48 | 0.95 | 38 | 79 | 16 | 33 |
Tacrolimus | 37 | 1.80 | 36 | 97 | 25 | 68 |
Levetiracetam | 35 | 2.21 | 25 | 71 | 3 | 9 |
Carbamazepine | 35 | 1.48 | 24 | 69 | 0 | 0 |
Bevacizumab | 34 | 1.43 | 34 | 100 | 3 | 9 |
Methotrexate | 33 | 0.43 | 31 | 94 | 11 | 33 |